Biochemical assays |
|
|
VDR-SRC2-3 interaction |
Fluorescence Polarization |
384 |
Alexa Fluor 647/Texas Red/Fluorescein |
VDR-SRC2 interaction |
Fluorescence |
|
Pull-down assay (ROX-antibody) |
VDR-ligand interaction |
Fluorescence Polarization |
384 |
Invitrogen Polarscreen |
VDR-Coregulator interaction (10 coactivators and corepressors) |
Fluorescence Polarization |
384 |
Alexa Fluor 647/Texas Red/Fluorescein |
|
|
|
|
|
|
TR alpha-SRC2-2 interaction |
Fluorescence Polarization |
384 |
Alexa Fluor 647/Texas Red/Fluorescein |
TR beta-SRC2-2 interaction |
Fluorescence Polarization |
384 |
Alexa Fluor 647/Texas Red/Fluorescein |
AR-SRC2-3 interaction |
Fluorescence Polarization |
384 |
Alexa Fluor 647/Texas Red/Fluorescein |
PPAR gamma-DRIP2 interaction |
Fluorescence Polarization |
384 |
Alexa Fluor 647/Texas Red/Fluorescein |
ER alpha-SRC2-3 interaction |
Fluorescence Polarization |
384 |
in the making |
ER beta-SRC2-3 interaction |
Fluorescence Polarization |
384 |
in the making |
RxR alpha-SRC2-3 interaction |
Fluorescence Polarization |
384 |
in the making |
|
|
|
|
|
|
GLO1 inhibition |
UV Detection |
384 |
|
GLO1 inhibition |
Fluorescence Intensity |
384 |
|
GLO1 inhibition |
UV Detection |
384 |
Kinetic assay |
|
|
|
|
|
|
|
|
|
|
In vitro preclinical assays |
|
|
Aqueous small molecule solubility |
UV/VIS |
384 |
Filter-based Assay (pH range) |
Permeability(PAMPA) |
UV/VIS |
96 |
Hexadecane method (pH range) |
Stability assay |
LCMS |
384 |
Single injection (pH range) |
logP (octanol/water) |
UV/VIS |
384 |
|
|
|
|
|
|
|
Heptatoxicity assay |
Luminescence |
384 |
HepG2/CellTiterGlo (Promega) |
Nephrotoxicity assay |
Luminescence |
384 |
HEK293/CellTiterGlo |
Cardiotoxicity assay |
Luminescence |
384 |
Cardiomyocytes/CellTiterGlo |
Neurotoxicity |
Luminescence |
384 |
Glial/CellTiterGlo |
Cardiotoxicity (hERG) |
automated patch clamp |
96 |
transfected HEK293T |
|
|
|
|
|
|
Livermicrosome metabolism |
LCMS |
96 |
stability |
Hepatocyte metabolism |
LCMS |
96 |
stability |
P450 metabolism |
LCMS/Luminescence |
96 |
metabolites |
Enzyme conjugation |
LCMS/Luminescence |
96 |
metabolites |
|
|
|
|
|
|
Plasma Protein Binding assay |
Fluorescence |
384 |
multiple fluorophores |
Plasma Protein Binding assay |
UV Detection |
384 |
filtration-based |
|
|
|
|
|
|
|
|
|
|
Cell-based assays |
|
|
VDR-coregulator recruitment |
Fluorescence resonance energy transfer (FRET) |
384 |
GeneBLAzer assay (Invitrogen) |
Gene-specific VDR-coregulator recruitment |
Luminescence |
384 |
24-hydroxylase promoter transcription assay |
VDR-coactivator interaction |
Luminescence |
384 |
VDR-SRC1 two-hybrid assay |
HL60 differentiation assay |
UV Detection |
384 |
|
|
|
|
|
|
|
rt-PCR |
Fluorescence |
96 |
A mix of 20 NR target gene primers and 10 cell lines |
|
|
|
|
|
|
AR-activated transcription |
Luminescence |
384 |
Agonist and Antagonist |
ER alpha-activated transcription |
Luminescence |
384 |
Agonist and Antagonist |
ER beta-activated transcription |
Luminescence |
384 |
Agonist and Antagonist |
PPAR alpha-activated transcription |
Luminescence |
384 |
Agonist and Antagonist |
PPAR gamma-activated transcription |
Luminescence |
384 |
Agonist and Antagonist |
PPAR delta-activated transcription |
Luminescence |
384 |
Agonist and Antagonist |
PxR-activated transcription |
Luminescence |
384 |
Agonist and Antagonist |
CAR-activated transcription |
Luminescence |
384 |
Agonist and Antagonist |
|
RxR alpha-activated transcription |
Luminescence |
384 |
Agonist and Antagonist |
|
|
|
|
|
|
GABA(A) receptor assay (a1b3y2) |
automated patch clamp |
96 |
Electrophysiology |
GABA(A) receptor assay (a2b3y2) |
automated patch clamp |
96 |
Electrophysiology |
GABA(A) receptor assay (a3b3y2) |
automated patch clamp |
96 |
Electrophysiology |
GABA(A) receptor assay (a4b3y2) |
automated patch clamp |
96 |
Electrophysiology |
GABA(A) receptor assay (a5b3y2) |
automated patch clamp |
96 |
Electrophysiology |
GABA(A) receptor assay (a6b3y2) |
automated patch clamp |
96 |
Electrophysiology |
|
|
|
|
|